Isolation of both Pseudozyma aphidis and Nocardia otitidiscaviarum from a mycetoma on the leg

International Journal of Dermatology

Volumn 50, Issue 6, 2011, Pages 714-719

  Chen, Bin ^a   Zhu, Lin Yu ^a   Xuan, Xuan ^a   Wu, Ling Jian ^a   Zhou, Tie Li ^a   Zhang, Xue Qi ^a   Li, Bing Xu ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; IMIPENEM; ITRACONAZOLE; MINOCYCLINE; OFLOXACIN; RIFAMPICIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEBRIDEMENT; DNA SEQUENCE; FUNGUS; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEG DISEASE; MALE; MEDICAL HISTORY; MYCETOMA; NOCARDIA; NOCARDIA OTITIDISCAVIARUM; NUCLEAR MAGNETIC RESONANCE IMAGING; PSEUDOZYMA APHIDIS; TISSUE CULTURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

HUMANS; LEG DERMATOSES; MALE; MIDDLE AGED; MYCETOMA; NOCARDIA; USTILAGINALES;

EID: 79956217890     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04814.x     Document Type: Article

References (33)

1. Welsh O, Vera-Cabrera L, Salinas-Carmona MC. Mycetoma. Clin Dermatol 2007; 25: 195-202.
2. Iwen P, Hinrichs S, Rupp M. Utilization of the internal transcribed spacer regions as molecular targets to detect and identify human fungal pathogens. Med Mycol 2002; 40: 87-109.
3. Brown-Elliott B, Brown J, Conville P, Wallace R Jr. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev 2006; 19: 259-282.
4. Fell J, Boekhout T, Fonseca A, et al. Biodiversity and systematics of basidiomycetous yeasts as determined by large-subunit rDNA D1/D2 domain sequence analysis. Int J Syst Evol Microbiol 2000; 50: 1351-1371.
5. Beaman B, Beaman L. Nocardia species: host-parasite relationships. Clin Microbiol Rev 1994; 7: 213-264.
6. Minero MV, Marin M, Cercenado E, et al. Nocardiosis at the turn of the century. Medicine 2009; 88: 250-261.
7. Munoz J, Mirelis B, Aragon LM, et al. Clinical and microbiological features of nocardiosis 1997-2003. J Med Microbiol 2007; 56: 545-550.
8. Maraki S, Scoulica E, Nioti E, Tselentis Y. Nocardial infection in Crete, Greece: review of fifteen cases from 2003 to 2007. Scand J Infect Dis 2009; 41: 122-127.
9. Hakawi AM, Al Rabiah FA. Clinical pattern of nocardiosis in Saudi Arabia: a case series. East Mediterr Health J 2008; 14: 966-971.
10. Shivaprakash MR, Rao P, Mandal J, et al. Nocardiosis in a tertiary care hospital in North India and review of patients reported from India. Mycopathologia 2007; 163: 267-274.
11. Poonwan N, Mekha N, Yazawa K, et al. Characterization of clinical isolates of pathogenic Nocardia strains and related actinomycetes in Thailand from 1996 to 2003. Mycopathologia 2005; 159: 361-368.
12. Kageyama A, Yazawa K, Ishikawa J, et al. Nocardial infections in Japan from 1992 to 2001, including the first report of infection by Nocardia transvalensis. Eur J Epidemiol 2004; 19: 383-389.
13. Clark NM, Braun DK, Pasternak A, Chenoweth CE. Primary cutaneous Nocardia otitidiscaviarum infection: case report and review. Clin Infect Dis 1995; 20: 1266-1270.
14. Alteras I, Feuerman EJ, Dayan I. Mycetoma due to Nocardia caviae. The first Israeli patient. Int J Dermatol 1980; 19: 260-262.
15. Saul A, Bonifaz A, Messina M, Andrade R. Mycetoma due to Nocardia caviae. Int J Dermatol 1987; 26: 174-177.
16. Alteras I, Feuerman EJ. The second case of mycetoma due to Nocardia caviae in Israel. Mycopathologia 1986; 93: 185-187.
17. Maiti PK, Ray A, Bandyopadhyay S. Epidemiological aspects of mycetoma from a retrospective study of 264 cases in West Bengal. Trop Med Int Health 2002; 7: 788-792.
18. Saarinen KA, Lestringant GG, Czechowski J, Frossard PM. Cutaneous nocardiosis of the chest wall and pleura-10-year consequences of a hand actinomycetoma. Dermatology 2001; 202: 131-133.
19. Alberts JH, Boyd AS. Nocardia otitidiscaviarum: an unusual Nocardia species causing a primary lymphocutaneous infectious process in a mildly immunosuppressed patient. Skinmed 2002; 1: 62-64.
20. Wada A, Matsuda S, Kubota H, et al. Primary lymphocutaneous nocardiosis caused by Nocardia otitidiscaviarum. Hand Surg 2002; 7: 285-287.
21. Fabre S, Gibert C, Lechiche C, et al. Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab. J Rheumatol 2005; 32: 2432-2433.
22. Thoms KM, Zimmermann O, Schupp P, et al. Nocardia otitidiscaviarum: cause of long-term cutaneous abscesses on the leg of an immunocompetent man. Arch Dermatol 2007; 143: 1086-1087.
23. Magalh es G, de Castro Oliveira S, de Brito Soares A, et al. Mycetoma caused by Nocardia caviae in the first Brazilian patient. Int J Dermatol 2009; 49: 56-58.
24. Sugita T, Takashima M, Poonwan N, et al. The first isolation of ustilaginomycetous anamorphic yeasts, Pseudozyma species, from patients' blood and a description of two new species: P. parantarctica and P. thailandica. Microbiol Immunol 2003; 47: 183-190.
25. Lin SS, Pranikoff T, Smith SF, et al. Central venous catheter infection associated with Pseudozyma aphidis in a child with short gut syndrome. J Med Microbiol 2008; 57: 516-518.
26. Teo L, Tay Y. Ustilago species infection in humans. Br J Dermatol 2006; 155: 1096-1097.
27. Basse C, Steinberg G. Ustilago maydis, model system for analysis of the molecular basis of fungal pathogenicity. Mol Plant Pathol 2004; 5: 83-92.
28. Kämper J, Kahmann R, lker MB, et al. Insights from the genome of the biotrophic fungal plant pathogen Ustilago maydis. Nature 2006; 444: 97-101.
29. Klosterman SJ, Perlin MH, Garcia-Pedrajas M, et al. Genetics of morphogenesis and pathogenic development of Ustilago maydis. Adv Genet 2007; 57: 1-47.
30. Ameen M, Arenas R. Developments in the management of mycetomas. Clin Exp Dermatol 2009; 34: 1-7.
31. Ameen M, Arenas R. Emerging therapeutic regimes for the management of mycetomas. Expert Opin Pharmacother 2008; 9: 2077-2085.
32. Kashima M, Kano R, Mikami Y, et al. A successfully treated case of mycetoma due to Nocardia veterana. Br J Dermatol 2005; 152: 1349-1352.
33. Damle DK, Mahajan PM, Pradhan SN, et al. Modified Welsh regimen: a promising therapy for actinomycetoma. J Drugs Dermatol 2008; 7: 853-856.